Integrated Wealth Concepts LLC Boosts Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Integrated Wealth Concepts LLC lifted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.7% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,129 shares of the biotechnology company’s stock after buying an additional 485 shares during the period. Integrated Wealth Concepts LLC’s holdings in Axon Enterprise were worth $7,244,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Westfield Capital Management Co. LP boosted its position in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC grew its position in Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Axon Enterprise by 1.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after buying an additional 9,090 shares during the last quarter. 1832 Asset Management L.P. raised its position in Axon Enterprise by 44.0% in the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after acquiring an additional 114,800 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its stake in Axon Enterprise by 13.9% in the second quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock valued at $108,496,000 after acquiring an additional 45,049 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

AXON has been the subject of several research analyst reports. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. JMP Securities upped their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Craig Hallum upped their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Finally, Robert W. Baird lifted their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $460.33.

Insiders Place Their Bets

In other news, President Joshua Isner sold 25,811 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the transaction, the president now directly owns 228,166 shares in the company, valued at approximately $82,103,253.44. This represents a 10.16 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Julie A. Cullivan sold 900 shares of the firm’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total value of $318,177.00. Following the transaction, the director now directly owns 3,653 shares in the company, valued at approximately $1,291,445.09. This represents a 19.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 135,256 shares of company stock worth $61,043,370 in the last ninety days. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Trading Up 5.3 %

Axon Enterprise stock opened at $669.87 on Wednesday. The stock has a market cap of $51.08 billion, a P/E ratio of 173.09, a PEG ratio of 14.00 and a beta of 1.01. Axon Enterprise, Inc. has a fifty-two week low of $229.02 and a fifty-two week high of $675.47. The firm’s fifty day moving average price is $493.10 and its 200-day moving average price is $382.63. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.